Clinical utility of ECAP dosing in a real-world population delivered via EVOKE therapy: the ECAP study

EVOKE therapy was associated with clinically meaningful improvements in a real-world chronic pain population across different subgroups and disease pathologies, with effects observed at trial end reproduced at post-implant visit.